Exactech exceeds $100M in '06 sales


Published: Tuesday, January 9, 2007 at 6:01 a.m.
Last Modified: Monday, January 8, 2007 at 12:00 a.m.

Gainesville-based Exactech exceeded $100 million in sales of its orthopedic implant products and services in 2006, according to the company.

Exactech makes bone and joint restoration products including orthopedic implants, surgical tools and biologic materials for hospitals and physicians at its 120,000-square-foot corporate headquarters in the Northwood Industrial Park. It is a publicly traded company — EXAC on Nasdaq — and is expecting final sales to total $102 million.

"Surpassing the $100 million mark is an important milestone in Exactech's history," Chairman and CEO Bill Petty said in a news release.

"It brings us more recognition as a publicly held company," said spokeswoman Priscilla Bennett. "It brings us more recognition in financial markets, more security for all our employees and really generates more pride in our organization for everyone involved."

Bennett cited increased sales to extensions to its hip line, growth in its shoulder and knee lines, a new temporary shoulder implant for infected joints and a new cement spacer.

As a result of supplier issues, the company also increased manufacturing of its own products, she said. The company employs more than 200 people.

In an industry dominated by the likes of Johnson & Johnson and DePuy, Exactech is the seventh-largest orthopedic products company, she said. "We play in an industry of Goliaths," Bennett said. "So to be able to have any piece of that pie and succeed for 22 years is pretty significant."

Exactech was founded in 1985 by Dr. William Petty, an orthopedic surgeon, and Gary Miller, a bioengineer, both formerly of the University of Florida College of Medicine, and Betty Petty. The company went public in 1996. Its products are distributed in the U.S. and 30 foreign countries.

Anthony Clark can be reached at anthony.clark@ gvillesun.com or 374-5094.

Reader comments posted to this article may be published in our print edition. All rights reserved. This copyrighted material may not be re-published without permission. Links are encouraged.

Comments are currently unavailable on this article

▲ Return to Top